Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 505 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Triple fixed drug combinations in type 2 diabetes

John Mathew, Gopinath Deepa, Kalra Sanjay

Year : 2015| Volume: 19| Issue : 3 | Page no: 311-313

   This article has been cited by
1 Comparative Study of Different Derivative Spectrophotometric Techniques for the Analysis and Separation of Metformin, Empagliflozin, and Glimepiride
Khanda F.M. Amin,Nabil A. Fakhre,Ahmed M. Abdullah
Current Pharmaceutical Analysis. 2020; 16(7): 916
[Pubmed]  [Google Scholar] [DOI]
2 Fixed-dose combination in management of type 2 diabetes mellitus: Expert opinion from an international panel
Sanjay Kalra,AK Das,G Priya,S Ghosh,RN Mehrotra,S Das,P Shah,S Bajaj,V Deshmukh,D Sanyal,S Chandrasekaran,D Khandelwal,A Joshi,T Nair,F Eliana,H Permana,MD Fariduddin,PK Shrestha,D Shrestha,S Kahandawa,M Sumanathilaka,A Shaheed,AA Rahim,A Orabi,A Al-ani,W Hussein,D Kumar,K Shaikh
Journal of Family Medicine and Primary Care. 2020; 9(11): 5450
[Pubmed]  [Google Scholar] [DOI]
3 Drug–drug cocrystals of anticancer drugs erlotinib–furosemide and gefitinib–mefenamic acid for alternative multi-drug treatment
Christy P. George,Shridhar H. Thorat,Parth S. Shaligram,Suresha P. R.,Rajesh G. Gonnade
CrystEngComm. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 Challenges for the pharmaceutical technical development of protein coformulations
Claudia Mueller,Ulrike Altenburger,Silke Mohl
Journal of Pharmacy and Pharmacology. 2017;
[Pubmed]  [Google Scholar] [DOI]


Read this article